America's Opioid Epidemic: Supply and Demand Considerations

被引:78
作者
Clark, David J. [1 ]
Schumacher, Mark A. [2 ]
机构
[1] Stanford Univ, Dept Anesthesiol, 3801 Miranda Ave, Palo Alto, CA 94304 USA
[2] UCSF, Div Pain Med, Dept Anesthesia & Perioperat Care, San Francisco, CA USA
关键词
DRUG-MONITORING PROGRAM; ABUSE-DETERRENT FORMULATIONS; LOCK-IN PROGRAMS; INDUCED HYPERALGESIA; UNITED-STATES; CHRONIC PAIN; EXTENDED-RELEASE; PRESCRIPTION; HEALTH; MANAGEMENT;
D O I
10.1213/ANE.0000000000002388
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
America is in the midst of an opioid epidemic characterized by aggressive prescribing practices, highly prevalent opioid misuse, and rising rates of prescription and illicit opioid overdose-related deaths. Medical and lay public sentiment have become more cautious with respect to prescription opioid use in the past few years, but a comprehensive strategy to reduce our reliance on prescription opioids is lacking. Addressing this epidemic through reductions in unnecessary access to these drugs while implementing measures to reduce demand will be important components of any comprehensive solution. Key supply-side measures include avoiding overprescribing, reducing diversion, and discouraging misuse through changes in drug formulations. Important demand-side measures center around educating patients and clinicians regarding the pitfalls of opioid overuse and methods to avoid unnecessary exposure to these drugs. Anesthesiologists, by virtue of their expertise in the use of these drugs and their position in guiding opioid use around the time of surgery, have important roles to play in reducing patient exposure to opioids and providing education about appropriate use. Aside from the many immediate steps that can be taken, clinical and basic research directed at understanding the interaction between pain and opioid misuse is critical to identifying the optimal use of these powerful pain relievers in clinical practice.
引用
收藏
页码:1667 / 1674
页数:8
相关论文
共 73 条
  • [61] Subera Layne E, 2014, J Okla State Med Assoc, V107, P416
  • [62] Substance Abuse and Mental Health Services Administration, 2012, MAN CHRON PAIN AD RE
  • [63] Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period
    Sun, Eric C.
    Darnall, Beth D.
    Baker, Laurence C.
    Mackey, Sean
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (09) : 1286 - 1293
  • [64] Trescot Andrea M, 2006, Pain Physician, V9, P1
  • [65] van Amsterdam Jan, 2015, Curr Drug Abuse Rev, V8, P3
  • [66] Impact of Perioperative Pain Intensity, Pain Qualities, and Opioid Use on Chronic Pain After Surgery A Prospective Cohort Study
    VanDenKerkhof, Elizabeth G.
    Hopman, Wilma M.
    Goldstein, David H.
    Wilson, Rosemary A.
    Towheed, Tanveer E.
    Lam, Miu
    Harrison, Margaret B.
    Reitsma, Michelle L.
    Johnston, Shawna L.
    Medd, James D.
    Gilron, Ian
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2012, 37 (01) : 19 - 27
  • [67] Biased ligands at G-protein-coupled receptors: promise and progress
    Violin, Jonathan D.
    Crombie, Aimee L.
    Soergel, David G.
    Lark, Michael W.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (07) : 308 - 316
  • [68] Opioid Abuse in Chronic Pain - Misconceptions and Mitigation Strategies
    Volkow, Nora D.
    McLellan, A. Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) : 1253 - 1263
  • [69] Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use
    Webster, Barbara S.
    Verma, Santosh K.
    Gatchel, Robert J.
    [J]. SPINE, 2007, 32 (19) : 2127 - 2132
  • [70] Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
    Webster, Lynn R.
    Markman, John
    Cone, Edward J.
    Niebler, Gwendolyn
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (01) : 102 - 110